Recent advances in anti-multidrug resistance for nano-drug delivery system

C Wang, F Li, T Zhang, M Yu, Y Sun - Drug Delivery, 2022 - Taylor & Francis
Chemotherapy for tumors occasionally results in drug resistance, which is the major reason
for the treatment failure. Higher drug doses could improve the therapeutic effect, but higher …

Advances in intelligent-responsive nanocarriers for cancer therapy

M Tian, X Xin, R Wu, W Guan, W Zhou - Pharmacological Research, 2022 - Elsevier
With the rapid development of nanotechnology, strategies related to nanomedicine have
been used to overcome the shortcomings of traditional chemotherapy drugs, thereby …

Dual-responsive triple-synergistic Fe-MOF for tumor theranostics

Z Chen, Y Sun, J Wang, X Zhou, X Kong, J Meng… - ACS …, 2023 - ACS Publications
The intelligent responsive drug delivery system has great application potential in cancer
precision therapy. Although many antitumor methods have been developed based on drug …

Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy

YH Dinakar, A Karole, S Parvez, V Jain, SL Mudavath - Life Sciences, 2022 - Elsevier
Lung Cancer (LC) is the malignant tumor of the lungs which is defined by the unrestricted
cell development in the lung tissues which if left untreated may migrate to different regions of …

Hyaluronic acid-empowered nanotheranostics in breast and lung cancers therapy

F Alsaikhan - Environmental Research, 2023 - Elsevier
Nanomedicine application in cancer therapy is an urgency because of inability of current
biological therapies for complete removal of tumor cells. The development of smart and …

[HTML][HTML] Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles

J Prieložná, V Mikušová, P Mikuš - International Journal of Pharmaceutics …, 2024 - Elsevier
Cancer is the leading cause of death globally, and conventional treatments have limited
efficacy with severe side effects. The use of nanotechnology has the potential to reduce the …

Nanomedicines for overcoming cancer drug resistance

T Hu, H Gong, J Xu, Y Huang, F Wu, Z He - Pharmaceutics, 2022 - mdpi.com
Clinically, cancer drug resistance to chemotherapy, targeted therapy or immunotherapy
remains the main impediment towards curative cancer therapy, which leads directly to …

Menthol causes mitochondrial Ca2+-influx, affects structure-function relationship and cools mitochondria

S Kumar, TK Acharya, RR Halder, P Mahapatra… - Life Sciences, 2023 - Elsevier
Menthol is a small bioactive compound able to cause several physiological changes and
has multiple molecular targets. Therefore, cellular response against menthol is complex, and …

Regulation of mitochondrial temperature in health and disease

Z El-Gammal, MA Nasr, AO Elmehrath… - … -European Journal of …, 2022 - Springer
Mitochondrial temperature is produced by various metabolic processes inside the
mitochondria, particularly oxidative phosphorylation. It was recently reported that …

Synergistic potential of nanomedicine in prostate cancer immunotherapy: breakthroughs and prospects

Y Jiang, C Wang, C Zu, X Rong, Q Yu… - International Journal of …, 2024 - Taylor & Francis
Given the global prevalence of prostate cancer in men, it is crucial to explore more effective
treatment strategies. Recently, immunotherapy has emerged as a promising cancer …